(1 reference)-
- Target Alle beta Amyloid (Abeta) Produkte
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
- Protein Region
- AA 12-20
- Reinheit
- > 95 %
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- -20 °C
-
-
: "Regulation of IL-1?-induced cyclooxygenase-2 expression by interactions of A? peptide, apolipoprotein E and nitric oxide in human neuroglioma." in: Journal of molecular neuroscience : MN, Vol. 47, Issue 3, pp. 533-45, (2012) (PubMed).
-
: "Regulation of IL-1?-induced cyclooxygenase-2 expression by interactions of A? peptide, apolipoprotein E and nitric oxide in human neuroglioma." in: Journal of molecular neuroscience : MN, Vol. 47, Issue 3, pp. 533-45, (2012) (PubMed).
-
- Target
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
- Synonyme
- AAA Peptide, ABETA Peptide, ABPP Peptide, AD1 Peptide, APPI Peptide, CTFgamma Peptide, CVAP Peptide, PN-II Peptide, PN2 Peptide, aaa Peptide, abeta Peptide, abpp Peptide, ad1 Peptide, appi Peptide, ctfgamma Peptide, cvap Peptide, pn2 Peptide, Abeta Peptide, Abpp Peptide, Adap Peptide, Ag Peptide, Cvap Peptide, E030013M08Rik Peptide, betaApp Peptide, amyloid beta precursor protein Peptide, amyloid beta (A4) precursor protein Peptide, APP Peptide, app Peptide, App Peptide
- Hintergrund
- Intracerebroventricular administration of synthetic peptides Abeta (12-20), (12-28), and (18-28) causes amnesia in mice. These peptides contain the amino acid residues VFF at position (18-20), suggesting that this triad has amnestic effects.
-
Sie sind hier:
